ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Historical evolution of the epidemiology of Malaria in Spain and Europe. Future perspectives.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vector-Borne Infections in Romania: From Surveillance to Prediction.Microorganisms · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria is a disease caused by a parasite of the Plasmodium species transmitted by anopheline mosquitoes that was officially eradicated in Spain in 1964 and in Europe in the 1970s through a combination of implementation of health programs with drug therapy, insecticide spraying and environmental engineering. Since then, the disease has been imported to the continent by international travelers and immigrants from endemic regions.
methodsDiverse medical articles in English and Spanish language, guides and official reports from International Health Organisms were selected, as well as the official WHO (World Health Organization) website (accessing its reports for the years 2023 and 2024) and ECDC (European Centre for Disease Prevention and Control) website with its annual epidemiological reports. The searches were clearly focused on providing answers to the main objective, which is to offer a historical, past and current description of epidemiology in Spain and Europe, and as secondary objectives, to consider how migratory and population movements, as well as climate change, may influence a new disease scenario and how we can anticipate the problems that will arise from this situations.
resultsNowadays there are a high number of imported cases, with autochthonous transmission in Europe being extremely infrequent, probably because of early diagnosis and treatment enabled by efficient healthcare systems. It is speculated that the current changing climatic conditions with warm temperatures and adequate humidity could favor the proliferation of anopheline mosquitoes and thus malaria transmission in several areas of southern Europe. In addition, the continuing massive influx of refugees and migrants from endemic areas could contribute to the creation of a reservoir of infectious parasites.
conclusionAlthough the disease potential in Europe is currently low, especially in the northern and western parts of the Continent, strengthening disease awareness and maintaining strong public health infrastructures for surveillance and vector control are of utmost importance to avoid the possibility of malaria transmission and re-emergence in the most vulnerable areas of Europe.
Indexed as
Identifiers
40932647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.